Congress promises to lower drug prices. But patients won’t see any cost savings at the pharmacy counter. We sort through the facts and myths of drug pricing, how “middlemen” in the supply chain lead to higher costs and real solutions …
COVID-19 continues to put the most vulnerable at risk, including the elderly and those with chronic illnesses. At its peak, it filled up hospitals and forced those seeking non-COVID care to postpone critical appointments. To protect patients and...
Patients depend on the research and development cycle to produce innovative, life saving medicines for rare and chronic conditions. But this medical innovation faces hurdles if Congress passes medicare price negotiations within the Build Back Better...
Numerous health policies are under debate in Congress. As Senators and Representatives hash out drug pricing legislation and more, where are patients in the conversation? Advocate and former Ohio state legislator Randi Clites shares how patients can...
As Congress continues to debate solutions to lower healthcare costs, biosimilars are a promising option. But uptake of biosimilars has been slow in the U.S., and few patients are seeing direct savings at the pharmacy counter. Brian Lehman, Director of...
President Biden outlines a new COVID-19 strategy, the U.S. Senate returns to Washington, and the House of Representatives debates prescription drug prices. Hosts Terry Wilcox and Dr. Bob Goldberg break down D.C.’s busy week and what chronic disease...
Want greater access to your doctor at a lower price? It’s possible through direct primary care. This healthcare solution allows patients to develop personal relationships with their doctors and receive care quicker and cheaper. Three physicians...
What can Congress do to aid in the fight against ovarian cancer? If reauthorized, Johanna’s Law would increase funding for ovarian cancer education and awareness programs. Ovarian Cancer Research Alliance’s VP of Policy, Chad Ramsey,...
Kids across the country are headed back to school. But as the Delta variant spreads, what should families living with chronic disease know to stay healthy and safe? Pediatrician Dr. Marlene Wust-Smith gives a back-to-school c...
What’s the purpose of a patent? In the pharmaceutical industry, it helps manufacturers reinvest in new research and development to improve upon treatments and drugs. It’s a key part of the cycle of developing new treatments. ...
Premiums, deductibles, and copays continue to rise as insurance companies grow fat through mergers and monopolies. Host Terry Wilcox speaks with former insurance executive-turned-advocate Wendell Potter. Together, they explor...
The Delta variant, a breakdown of the FDA’s accelerated approval process, and how pink socks are bringing together patient advocacy groups. Hosts Dr. Bob Goldberg and guest host Kate Pecora dive into the news of the week, inc...
Opioid overdoses are rising as the COVID-19 pandemic continues. In 2020, overdose deaths rose by 30%. However, many chronic disease patients rely on prescription opioids for their healthcare regimen. We examine a balanced pol...
The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker price? (Spoiler alert: No!). Co-host Dr. Bob Goldberg explains the research/value assessment of the ...
Access to all of your health data - MRIs, screenings, and lab results - could be right at your fingertips. COVID-19 put healthcare tech companies into high gear to deliver health data to patients. The end result? Empowered pa...
Patients depend on safety and accuracy of medical equipment. If they’re improperly repaired, it could derail a patient’s healthcare journey and risk their health and safety. The Right to Repair Act aims to expedite medical de...
Doctor’s visits, tests, procedures and therapies are just one part of a healthcare journey. Knowing and understanding the laws that govern and protect your right to work, along with health insurance coverage and reimbursement...
Drama continues to unfold following the FDA’s controversial approval of a new Alzhiemer’s treatment. Members of the FDA’s advisory committee voted against approval, and some members resigned in protest. But how does this impa...
A new FDA-approved drug for Alzheimer’s signals a breakthrough in innovation for patients and caregivers, but has raised doubts from some over the price tag and approval process. Confused about what all of this means for you?...
Following a pandemic that exposed disparities, and failures to patients with chronic disease, now is the time for lawmakers and the industry in the U.S. to rethink its approach to healthcare. On this episode: how to create su...
Can you tell the difference between an advertising claim and research-backed statistics? For chronic disease patients who take supplements to manage their conditions, this is an ongoing problem. And the Food and Drug Administ...
More than 60 million Americans live with allergies or asthma. COVID-19 brought much needed attention to lung and respiratory challenges, but where do allergy and asthma patients go now in this emerging post-pandemic world? To...
Demands for mental and behavioral health services are on the rise. These services represented nearly half of all telehealth claims during the pandemic, but the digital divide and lack of in-network mental health providers cre...
When it comes to saving a buck, rare and chronic disease patients are too often put on the chopping block. Accelerated approval drugs are key to treating life threatening diseases. So why is Medicaid and CHIP Payment and Acce...